Distribution Siva Nageswararao Mekala Assistant professor

Slides:



Advertisements
Similar presentations
HLTH 340 Lecture A4 Toxicokinetic processes: Distribution (part-1)
Advertisements

Disposition of Chemical Compounds. Four Phases To Disposition of Chemical Compounds Absorption of Chemicals into the Body Distribution of Chemicals within.
Drugs Used During Pregnancy & Lactation
Module 2 # 2 Pharmacokinetics absorption of drugs drugs can be given iv, im, sc, orally (po) if given parenterally, they should.
VM 8314 Dr. Wilcke Drug Distribution. VM 8314 Dr. Wilcke  Vascular space =  Plasma/plasma water + (extracellular space)  Many RBC’s (intracellular.
DISTRIBUTION The body is a container in which a drug is distributed by blood (different flow to different organs) - but the body is not homogeneous. Factors.
Principles of Pharmacology. SOURCES AND NAMES OF DRUGS Sources of Drugs Many drugs are isolated from plants or chemically derived from plant substances.
BioavailabilityDistribution Absorption and Transport.
One-compartment open model: Intravenous bolus administration
Asmah Nasser, M.D. Pharmacokinetics.
Pharmacokinetics Chapter 4.
SEMINAR ON VOLUME OF DISTRIBUTION BY SUMAN.THOTA M.PHARM 1 ST YEAR (1 ST SEM) INDUSTRIAL PHARMACY U.C.P.SC.
Pharmacokinetics Based on the hypothesis that the action of a drug requires presence of a certain concentration in the fluid bathing the target tissue.
Pharmacology Department
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
Is the passage of drug from its site of administration to its site of action through cell membranes. Sites of Administration Sites of action Cell membrane.
Prof. Hanan Hagar Pharmacology Department. What student should know  Major body fluid compartments  Concept of compartments.  Apparent volume of distribution.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
Prof. Hanan Hagar Pharmacology Department.  Is the fraction of unchanged drug that enters systemic circulation after administration and becomes available.
Drug excretion in milk: Mechanisms of transfer from blood to milk : low molecular weight 1-Diffusion of water soluble low molecular weight substances.
PHARMACOKINETICS CH. 4 Part 2. GETTING IN ABSORPTION Definition – the movement of a drug from the site of administration into the fluids of the body.
Pharmacology Department
1 Pharmacology Pharmacokinetics –Absorption –Distribution –Biotransformation (metabolism) –Excretion Pharmacodynamics –Receptor binding –Signal transduction.
Basic Pharmacokinetics The time course of drug action Collected and Prepared By S.Bohlooli, PhD.
PHARMACOKINETIC MODELS
Drug distribution and protein binding
ADVANCED PHARMACOKINETICS Prof. Dr. Henny Lucida, Apt.
DISTRIBUTION OF DRUG Dr. Muslim Suardi Faculty of Pharmacy University of Andalas 2009.
Quantitative Pharmacokinetics
Pharmacology Department
Plasma Protein Binding
PHARMACOKINETICS Definition: quantitative study of drug absorption, distribution, metabolism, and excretion (ADME), and their mathematical relationship.
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
Definition: the intestinal, then hepatic degradation or alteration of an ingested medication before it enters the general circulation All blood that.
Pharmacology Department
Local Anaesthesia and Vasoconstrictors
Principles of Drug Action
Clinical Pharmacokinetics Department of Pharmacology.
By : Dr. Roshini Murugupillai
Compartmental Models and Volume of Distribution
Pharmacokienetic Principles (2): Distribution of Drugs
BASIC PHARMACOKINETIC PARAMETERS
Basic Principles: PK By: Alaina Darby.
Distribution It the process by which a drug reversibly leaves blood and enter interstitium (extracellular fluid) and/ or cells of tissues. Primarily depends.
Drug therapy in pediatric
Chapter 3 PHARMACOKINETICS “What the body does to the drug” Lei Wang
General principles of pharmacology
ISHIK UNIVERSITY FACULTY OF DENTISTRY
Medicinal chemistry Third stage Lecture 1
Lecture-8 Biopharmaceutics
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
Pharmaceutics 2.
Bioavailability and distribution
Pharmacokinetics: Drug Distribution and Drug Reservoirs
Factors affecting Drug Activity
Introduction to Pharmacology
Pharmacokinetics.
Pharmacokinetics: Drug Distribution and Drug Reservoirs
School of Pharmacy, University of Nizwa
Hawler Medical University
Clinical Pharmacokinetics
Biopharmaceutics Chapter-6
School of Pharmacy, University of Nizwa
SIVANAGESWARARAO MEKALA
Clinical Pharmacokinetics
CHAPTER 4 l. VanValkenburg, RVT, BAS
BIOAVAILABILITY.
Pharmacokinetics/Pharmacodynamics
Pharmacokinetics Asst Prof Dr Inam S. Arif
Drug-drug Interactions
Presentation transcript:

Distribution Siva Nageswararao Mekala Assistant professor Dept. of clinical pharmacology Faculty of medicine

DISTRIBUTION Distribution is defined as the reversible transfer of drugs between body fluid compartments Depends upon lipid solubility of the drug, ionization at physiological pH, extent of binding to plasma proteins, and tissue proteins, blood flow to tissues.

Volume of Distribution An abstract concept Gives information on HOW the drug is distributed in the body Used to calculate a loading dose

3 L

Apparent volume of distribution (aVd): aVd is defined as the hypothetical volume of the body fluid into which a drug is uniformly distributed at a concentration equal to that in plasma ,assuming the body to be a single compartment. TOTAL AMOUNT OF DRUG IN THE BODY aVd = ……………………………………………………….. CONCENTRATION OF THE DRUG IN PLASMA Lipid insoluble drugs do not enter cells, so aVd is approximates ECF volume . Drugs extensively bound to plasma proteins eg: warfarin, phenylbutazone, are largely restricted to vascular compartment and have low values

Clinical importance of Vd : Aspirin Vd = 0.1571 L/Kg ; Pethidine Vd = 280 L/Kg Hemodialysis is useful only for drugs with small volume of distribution e.g. aspirin

Factors governing volume of distribution 1. Physicochemical properties of the drug: Lipid soluble and unionized form of drugs readily cross the cell membrane and are widely distributed. Eg: Lignocaine ,Propranolol 2. Degree of plasma protein binding: Drugs that are highly bound to plasma proteins have a low volume of distribution Eg: warfarin, phenytoin

5. Fat : Lean body mass ratio: Highly lipid soluble drugs 3. Tissue storage : Certain drugs can get sequestrated in some tissues. such drugs have a large Vd Eg: Digoxin is sequestrated in heart, muscle ,liver etc and has Vd is 63L/Kg 4. Disease states: The volume of distribution of drugs can be altered in certain diseases Eg: In CHF ,the Vd of some drugs can be increase due to increase in ECF volume 5. Fat : Lean body mass ratio: Highly lipid soluble drugs get distributed to the adipose tissue.

Redistribution Highly lipid soluble drugs such as Thiopentone sodium , on I.V administration immediately gets distributed to areas of high blood flow such as Brain and causes general anesthesia . Immediately with in a few minutes ,it recrosses the BBB and gets distributed into the blood and then to the less perfused tissues such as muscle and adipose tissue . This is called redistribution ,which results in termination of drug action.

Blood Brain Barrier (BBB) The capillary boundary that is present between the blood and brain is called BBB Barbiturates, diazepam, volatile anesthetics, amphetamine etc – cross BBB

The unique characteristics of brain capillary endothelial cells and pericapillary glial cells constitute the blood-brain barrier. The lipid insoluble and ionized particles do not cross the BBB. EG: Dopamine , Aminoglycosides Meningitis, encephalitis - increase the permeability of the BBB eg. penicillin in normal conditions has poor penetration through BBB, but its penetrability increases during meningitis and encephalitis.

Placental Barrier : The lipid membrane between the mother and fetus is called placental barrier. Unionized and lipid soluble drugs can freely cross the placental barrier. e.g. anesthetics, alcohol, morphine etc. Quaternary ammonium compounds e.g.. d-TC and substances with high molecular weight e.g.. insulin cannot cross the placental barrier. The fetal plasma is slightly more acidic than that of the mother (pH 7.0 to 7.2 versus 7.4), so that ion trapping of basic drugs occurs.

Certain drugs when given during pregnancy may cross the placenta and cause various dangerous effects in the foetus called teratogenic effect. Eg: Thalidomide -Phocomelia Tetracyclines – Yellowish discoloration of the teeth Anti thyroid drugs – Foetal goiter

Plasma protein binding To albumin (Acidic drugs ) Barbiturates Benzidiazepines NSAIDS Valproicacid Phenytoin Penicillins Sulfonamides Tetracyclines Tolbutamide Warfarin To alpha 1 glycoprotein (Basic Drugs ) Beta blockers Bupivacaine Lignocaine Disopyramide Imipramine Methadone Prazocin Quinidine Verapamil

Importance of plasma protein binding 1) high plasma protein binding drugs have lower volumes of distribution . 2) bound fraction is not available for action but in equilibrium with free drug in plasma. 3) high degree of plasma binding makes drug longer acting.

4)generally expressed conc. of the drug refer to both bound and free conc. of the drug. 5)one drug can bind to many sites of plasma protein and a plasma protein can bind to many drugs. 6) Displacement of drugs is seen. More than one drug bing to the same site on Albumin . The drug with higher affinity will displace the one having lower affinity and may results in a sudden increase in the free concentration of the drug with lower affinity . E.g.: phenylbutazone and salicylates displace tolbutamide. Indomethacin and phenyl butazone displace warfarin.

7) pathological states like hypoalbuminemia binding is reduced (severe liver disease or the nephrotic syndrome ) In cases of acute-phase reaction response (e.g., cancer, arthritis, myocardial infarction, and Crohn's disease) lead to elevated levels of a1- acid glycoprotein and enhanced binding of basic drugs. Highly protein bound drugs have a longer duration of action and hence difficult to remove. In cases of poisoning, highly plasma protein bound drugs are difficult to be removed by Hemodialysis.

Tissue storage: Skeletal muscle,heart - digoxin,emetine Liver - choloroquine, Tetracyclines Kidney - chloroquine,digoxin Thyroid - iodine Brain - chlorpromazine, Isoniazid Bone and teeth - tetracyclines,metals Adipose tissue - thiopentone , ether